width=With a research grant from the A-TCP, Ronald Hart, PhD at Rutgers University in New Jersey will create induced pluripotent stem cells (iPSCs) using blood samples taken from kids with A-T. Disease-specific iPSCs are often called “disease in a dish” models, because they allow scientists to study a disease using cells in culture, outside of a human or animal body.

Especially exciting, with the right stimulation, it may be possible to turn the iPSCs into brain cells, providing a way for neuroscientists to learn more about how A-T affects the brain. In addition, iPSCs can be used to screen chemical compounds for potential new drugs.

Oops! We could not locate your form.

Related News

Jul 22 @ 8:05 pm

Gene Therapy for A-T Conference Announced For This Fall

The A-TCP is hosting an international Gene Therapy for A-T conference in November.

more
Jul 22 @ 8:05 pm

Art of Nursing Award

A-T Clinic Nurse, Jenny Wright, RN is the recipient of the 2024 Art of Nursing award!

more
Jul 22 @ 8:05 pm

Shining a Light on A-T at the IlluminATion Ball

The A-TCP is hosting IlluminATion: A BioPharma Leadership Ball on May 11 in Boston to shine a light

more
Jul 22 @ 8:05 pm

NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid

Quince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia

more